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ABSTRACT We have recently identified farnesol, an intermediate in the mevalonate pathway, as a potent endogenous
modulator and blocker of N-type calcium channels (Roullet, J. B., R. L. Spaetgens, T. Burlingame, and G. W. Zamponi. 1999.
J. Biol. Chem. 274:25439–25446). Here, we investigate the action of structurally related compounds on various types of
voltage-dependent Ca2 channels transiently expressed in human embryonic kidney cells. 1-Dodecanol, despite sharing the
12-carbon backbone and headgroup of farnesol, exhibited a significantly lower blocking affinity for N-type Ca2 channels.
Among several additional 12-carbon compounds tested, dodecylamine (DDA) mediated the highest affinity inhibition of
N-type channels, indicating that the functional headgroup is a critical determinant of blocking affinity. This inhibition was
concentration-dependent and relatively non-discriminatory among N-, L-, P/Q-, and R-Ca2 channel subtypes. However,
whereas L-type channels exhibited predominantly resting channel block, the non-L-type isoforms showed substantial rapid
open channel block manifested by a speeding of the apparent time course of current decay and block of the inactivated state.
Consistent with these findings, we observed significant frequency-dependence of block and dependence on external Ba2
concentration for N-type, but not L-type, channels. We also systematically investigated the drug structural requirements for
N-type channel inhibition. Blocking affinity varied with carbon chain length and showed a clear maximum at C12 and C13,
with shorter and longer molecules producing progressively weaker peak current block. Overall, our data indicate that aliphatic
monoamines may constitute a novel class of potent inhibitors of voltage-dependent Ca2 channels, with block being
governed by rigid structural requirements and channel-specific state dependencies.
INTRODUCTION
Calcium entry through voltage-gated channels mediates a
variety of physiological responses such as muscle contrac-
tion, control of pacemaker activity, neurotransmitter re-
lease, activation of Ca2-dependent proteins, and induction
of gene transcription (e.g., McCleskey, 1994; Dickson et al.,
1997; Lemos and Nowycky, 1989; Higuchi et al., 1996).
Consequently, Ca2 channels are important pharmacologi-
cal targets in designing treatments for cardiac arrhythmias,
stroke, migraine, cerebellar ataxia, and some forms of epi-
lepsy (e.g., Camm et al., 1991; Ophoff et al., 1996; Fletcher
et al., 1996). Thus, it is of importance to understand the
molecular determinants governing the interactions between
drugs and the channel protein, and it is desirable to identify
novel classes of compounds that interact with these channels.
Neuronal Ca2 channels are heteromultimers of 1, 2,
, and  subunits. The 1 subunit, consisting of four repeat
domains of six transmembrane helices and a P-loop, pro-
vides the pore, voltage sensor, and inactivation machinery
of the channel (Catterall, 1991). To date, as many as 10 1
subunit genes have been identified, which are classified into
the low voltage-activated (LVA) T-type channels and the
high voltage-activated (HVA) N-, L-, P-, Q-, and R-types
based on diverse biophysical and pharmacological proper-
ties (for review, see Tsien et al., 1991; Zhang et al., 1993).
1C, 1D, 1F, and 1S encode L-type Ca
2 channels (Tom-
linson et al., 1993; Williams et al., 1992b; Bech-Hansen et
al., 1998; Ellis et al., 1988), 1A makes P/Q-type channels
through alternative splicing (Bourinet et al., 1999), 1B
gives rise to N-type channels (Williams et al., 1992a), 1E
is a unique type with characteristics common to both LVA
and HVA channels (Williams et al., 1994), and 1G, 1H,
and 1I encode T-type Ca
2 channels (Perez-Reyes et al.,
1998; Cribbs et al., 1998; Lee et al., 1999). The 1 subunit
is the target for most of the known Ca2 channel blockers
(for review, see Zamponi, 1997), and the particular phar-
macological profile is frequently used as a key characteristic
to help identify a given Ca2 channel subtype. For example,
-conotoxins GVIA and MVIIA are specific for the 1B
subunit (e.g., Boland et al., 1994; Fox, 1995), -agatoxin
IVA is selective for 1A (e.g., Mintz et al., 1992), and
dihydropyridines are specific blockers of the L-type iso-
forms (e.g., Bangalore et al., 1994). In addition, there are
many types of far less selective Ca2 channel blockers that
may reflect the overall degree of homology among individ-
ual Ca2 channel subtypes (i.e., Zamponi, 1997).
Recently, we have shown that farnesol, an intermediate of
the mevalonate pathway, mediates both a selective high
affinity (100 nM) inhibition of inactivated 1B channels and
a non-selective lower affinity (5–10 M) resting/open chan-
nel block of all types of HVA channels (Roullet et al.,
1999). Here, we examine the action of a series of commer-
cially available farnesol analogs on Ca2 channels tran-
siently expressed in human embryonic kidney (HEK) cells.
Among several 12 carbon chain molecules tested, dode-
cylamine (DDA) was identified as a highly potent inhibitor
of HVA channels. Qualitatively similar to farnesol, DDA
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caused a nonselective peak current inhibition of all types of
Ca2 channels tested, with block of the L-type channels
differing from that of non-L-type isoforms in its state-
dependence, use-dependence, and dependence on the exter-
nal permeant ion concentration. Experiments with a series
of additional aliphatic monoamines differing only in carbon
chain length revealed strict drug structural requirements for
N-type channel inhibition, with maximum inhibition occur-
ring at a chain length of 13 carbons. Overall, our data show
that remarkably simple small organic molecules may have
the propensity to potently inhibit neuronal calcium channels.
MATERIALS AND METHODS
Materials
Rat brain cDNAs coding for 1A, 1B, 1C, 1E, and 2- were donated by
Dr. T. P. Snutch (University of British Columbia). The following com-
pounds were obtained from Sigma (St. Louis, MO): n-nonylamine, n-
decylamine, DDA, n-dodecane; Aldrich (Milwaukee, WI): tridecylamine,
1-tetradecylamine, pentadecylamine, 1-hexadecylamine, octadecylamine,
1-dodecanol, 4-dodecylphenol (mixture of isomers), dodecylacetate; and
Acros (New Jersey, NJ): n-undecylamine. Drugs were stored as 100 mM
stock solutions in 100% ethanol and diluted into the appropriate external
recording solutions at the final concentrations necessary. The final ethanol
concentrations in the drug solutions (0.01%), when tested alone, have
previously been shown to have no effect on calcium channel currents
(Roullet et al., 1999).
Cell culture and transient transfection of
HEK cells
HEK tSA 201 cells were cultured in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% fetal bovine serum, 200 U/ml penicillin,
and 0.2 mg/ml streptomycin at 37°C with 5% CO2. At 85% confluency,
cells were split with 0.25% trypsin-1 mM EDTA and plated at 10%
confluency on glass coverslips. At 12 h, medium was replaced and cells
were transiently transfected, using a standard calcium phosphate protocol,
with cDNAs encoding calcium channel 1, 2-, and 1b subunits and
green fluorescent protein (EGFP, Clontech) at a 3:3:3:2 ratio. Fresh
DMEM was supplied and cells were moved to 28°C, 5% CO2 at 12 and
24 h after transfection, respectively. Cells were stored 1–2 days before
recording. All tissue culture reagents were obtained from Life Technolo-
gies, Inc. (Grand Island, NY).
Electrophysiological recordings and analysis
Voltage-clamp data acquired using pClamp version 6.0.3 software (Axon
Instruments, Foster City, CA) were filtered at 1 kHz via an Axopatch 200B
amplifier (Axon Instruments) and stored on an IBM-compatible PC. Bo-
rosilicate glass patch pipettes (Sutter Instrument Co., Novato, CA) were
polished (Microforge, Narishige, Japan) to a resistance of 4 M when
filled with cesium methanesulfonate internal solution (composition in mM:
109 CsCH3SO4, 4 MgCl2, 9 EGTA, 9 HEPES, pH 7.2). Cells were bathed
in external solution containing either 20 mM BaCl2, 1 mM MgCl2, 10 mM
HEPES, 40 mM tetraethylammonium chloride, 10 mM glucose, 65 mM
CsCl (pH 7.2) or 2 mM BaCl2, 1 mM MgCl2, 10 mM HEPES, 40 mM
tetraethylammonium chloride, 10 mM glucose, 105 mM CsCl (pH 7.2).
Unless stated otherwise, current data shown were elicited by a 0.066 Hz
train of 100-ms test pulses from 100 mV to various potentials (min. 20
mV, max. 30 mV). Drugs were perfused directly into the vicinity of the
cells using a home-built microperfusion system capable of solution ex-
changes in less than one second.
Data were analyzed using Clampfit 6.0 (Axon Instruments). The time
constant of current decay was measured at various DDA concentrations by
exponential fits to the raw data. The control decay rate was fit with a single
exponential with time constant h, while currents in the presence of DDA
were fit with a double exponential with one of the time constants fixed at
the control h value. The inverse of  was then plotted as a function of DDA
concentration. Assuming a 1:1 open channel blocking interaction, 1/ 
[D]kon  koff, where [D] is the drug concentration and kon and koff are,
respectively, the blocking and unblocking rate constants.
Normalized dose-response curves were fit (SigmaPlot 4.0, SPSS Inc.,
Chicago, IL) by the Hill equation to determine IC50 values. Steady-state
inactivation curves were plotted as the normalized test pulse amplitude
following 5-s inactivating prepulses in 10-mV increments. Inactivation
curves were fit (SigmaPlot 4.0) with the Boltzmann equation, Ipeak (nor-
malized)  1/(1  exp((V  Vh)z/25.6)), where V and Vh are the condi-
tioning and half-inactivation potentials, respectively, and z is the slope
factor. All error bars show standard error of the mean; any numbers in
parentheses shown in a figure reflect the numbers of experiments, and p
values reflect paired or Student’s t-tests.
RESULTS
An amine headgroup enhances N-type calcium
channel block by linear C12 compounds
We have previously shown that farnesol mediates a high
affinity modulation of inactivated N-type calcium channels
and a lower affinity non-selective block of all types of
neuronal HVA calcium channels (Roullet et al., 1999). To
elucidate some of the underlying drug structural require-
ments, we examined the effects of several commercially
available farnesol derivatives on transiently expressed N-
type calcium channels (bathed in 20 mM Ba2), and com-
pared them to those previously observed with farnesol. Like
farnesol, 1-dodecanol (see Fig. 1) exhibits a C12 hydrocar-
bon chain backbone and an alcohol group; however, the
double bonds and three methyl groups of farnesol are lack-
ing. At a concentration of 10 M and a holding potential of
100 mV, 1-dodecanol caused a 14  2% inhibition of
peak current amplitude of N-type calcium channels. This
was significantly lower than that observed with farnesol
(38  4%), indicating that either the more rigid double
bonds or the added hydrophobicity associated with the three
methyl groups in farnesol serve to enhance blocking affin-
ity. To examine a putative role of the alcohol group for
calcium channel block, we then varied the functional group
attached to the dodecyl backbone (see Fig. 1). Whereas 10
M n-dodecane, 4-dodecylphenol, and dodecylacetate
failed to produce more than about a 15% inhibition of peak
current amplitude, application of 10 M DDA virtually
completely (97  1%) eliminated the N-type currents (Fig.
1 B). Thus, the addition of an amine headgroup to the
dodecyl backbone structure mediated an almost 30-fold
increase in blocking affinity, well exceeding that observed
originally with farnesol. These data indicate that the func-
tional group attached to the dodecyl backbone is a critical
determinant of blocking affinity, and that aliphatic mono-
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amines have the propensity to potently block voltage-de-
pendent calcium channels. To further characterize the action
of DDA, and to test whether the basic blocking properties
previously observed with farnesol were preserved with the
structurally simpler DDA, we carried out a detailed charac-
terization of DDA block on four different types of high
voltage-activated calcium channels.
DDA mediates both resting and open
channel block
In order to test for a putative calcium channel isoform
selectivity of DDA block, 1A, 1B, 1C, and 1E channels
(coexpressed with 1b and 2- in tSA-201 cells) were
exposed to various concentrations of DDA. Fig. 2 A shows
representative current traces for each of the channel sub-
types bathed in 20 mM Ba2. In all cases, DDA induced a
reversible reduction in peak current amplitude, with 1C
exhibiting the most pronounced inhibition as evident by
comparing the effect of 3 M DDA on the current traces.
This is also reflected in the dose-response curves depicted in
Fig. 2 B. The IC50 values obtained from the fits were,
respectively, 0.8 M, 1.8 M, 2.0 M, and 2.1 M for 1C,
1B, 1E, and 1A, indicating a two to threefold higher
affinity for L-type compared to non-L-type channels, but
overall a poor selectivity among individual calcium channel
subtypes. For all channel types examined, the inhibition of
peak current amplitude exhibited little if any detectable
dependence on test potential (not shown).
Similar to what we had previously observed with farne-
sol, DDA mediated a speeding of the apparent time course
of inactivation. If DDA binding simply speeds inactivation
of the channel, the drug-bound channels would inactivate
with the faster rate, whereas the non-bound channels would
inactivate normally, thus yielding a double-exponential
macroscopic decay rate. With increasing drug concentra-
tions, the proportion of the drug-bound channels, and thus
the contributions of the faster inactivation time constants to
the overall inactivation rate, would increase, but the abso-
lute values of the two time constants should remain inde-
pendent of DDA concentration. In contrast, if the speeding
were due to open channel block developing during the test
depolarization, the rate of development of block, and thus
the DDA-induced second time constant, would be expected
to depend inversely on DDA concentration. To discriminate
between these two alternatives, the time course of current
decay in the presence of various DDA concentrations was
fit with two exponentials ( and h), where h was fixed at
the value obtained in the absence of DDA (see Methods). As
seen from Fig. 2 C, the inverse of the DDA-induced second
time constant () increased linearly with DDA concentra-
tion, consistent with the open channel blocking model and
our previous observations with farnesol (Roullet et al.,
1999). In this scenario, the slope and y-intercept of the
regression line would reflect the blocking and unblocking
rate constants, respectively (see Methods). As seen from
Fig. 2 C, block of the three non L-type channels occurred
with similar kinetics, whereas L-type channels exhibited
FIGURE 1 Peak current block of N-type calcium channels by farnesol
analogs. (A) Chemical structures of farnesol and a series of derivatives with
a C12 backbone. Note that these farnesol analogs differ only in their
functional groups. (B) Effect of application of 10 M concentrations of the
compounds depicted in A on N-type (1B  2-  1b) currents carried
by 20 mM barium. Currents were elicited by stepping from 100 mV to
10 mV at 15-s intervals. The data are plotted as peak current remaining
after drug application. Note that dodecylamine (DDA) mediates the most
pronounced inhibition of N-type channels. Current remaining: farnesol,
62  4%; 1-dodecanol, 86  2%; DDA, 3  1%; n-dodecane, 90  3%;
4-dodecylphenol, 86  2%; and dodecylacetate, 94  4%. Numbers in
parentheses indicate the numbers of experiments, the error bars reflect
standard errors.
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about twofold slower blocking and unblocking rate con-
stants. Overall, these data may indicate that the open chan-
nel blocking site is highly conserved across different types
of voltage-dependent calcium channels. For each of the
channels examined, open channel block could account for
only part of the overall inhibition observed at the time of
peak, thus suggesting the presence of an additional tonic
(i.e., resting channel) blocking component. Among the four
channel types examined, the L-type isoform was subject to
the largest contribution from resting block, which could
account for nearly 90% of the peak current reduction ob-
served in the presence of 1 M DDA. A substantial contri-
bution from resting channel block was also observed with
1B, which contrasts with our previous observations with
farnesol, where the peak current inhibition of 1B could be
attributed almost exclusively to open channel block devel-
oping during the activation phase (Roullet et al., 1999). In
contrast, the inhibition seen at the end of the test depolar-
FIGURE 2 Comparison of DDA effects on various types of calcium channels. (A) Current records obtained for four Ca2 channel subtypes. Currents
were evoked as described for Fig. 1, the external barium concentration was 20 mM. All subtypes showed reversible peak current inhibition by 3 M DDA.
Note an apparent speeding of inactivation is also evident in 1A, 1B, and 1E, and to a smaller degree, in 1C current traces. (B) Comparison of
dose-dependence of peak current inhibition of HVA calcium channels by DDA. Data were plotted as peak current mean  SEM and fit with the Hill
equation. Each data point reflects between 6 and 10 determinations. 1C was most sensitive to DDA with an IC50 of 0.8  0.1 M (nh  2.4) followed
by 1B, 1E, and 1A at 1.8  0.2 (nh  1.7), 2.0  0.2 (nh  1.3), and 2.1  0.6 M (nh  1.4), respectively. (C) Kinetic analyses of the dose-dependent
increase in the rate of apparent current decay with DDA for each calcium channel tested. Current records were fit as described in the Methods, and the
DDA-induced time constant  was plotted as a function of DDA concentration. Plots were fit with the linear regression equation 1/  koff  kon[DDA].
The values obtained from the fits were as follows: 1A, kon  0.024 M
1 ms1, koff  0.023 ms
1; 1B, kon  0.023 M
1 ms1, koff  0.0443 ms
1;
1C, kon  0.014 M
1 ms1, koff  0.019 ms
1; and 1E, kon  0.0265 M
1 ms1, koff  0.0546 ms
1. (D) Time course of 1B current inhibition by
DDA. The normalized 1B peak current elicited by consecutive step pulses to 10 mV was plotted showing control, 1 M DDA, 10 M DDA, and wash
responses. The magnitude of block and the rate of block development increased with the higher DDA concentration as expected, and the effect was fully
reversible. Note that the block by 1 M DDA reached equilibrium within two minutes, the equilibration time used for steady-state inactivation and
frequency-dependence experiments (see below).
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ization is predominantly due to open channel block, with
some contribution from the initial tonic block.
The kinetic analysis depicted in Fig. 2 C suggests that
after drug equilibration, block and unblock of the channels
occurs in the range of milliseconds. This contrasts with the
much slower time course of development of, and recovery
from, peak current inhibition of 1B evident in Fig. 2 D, which
occurred over the course of one to two minutes. Thus, similar
to what we had observed, with farnesol, DDA block of HVA
calcium channels appears to involve a rate-limiting step other
than the true interaction rates between the blocker and the
channel, such as partitioning into the plasma membrane.
DDA mediates inactivated channel block of
non-L-type channels
One of our key observations with farnesol was a selective
inhibition of inactivated N-type calcium channels (Roullet
et al., 1999) demonstrated by a farnesol-mediated shift in
half-inactivation potential. To test whether DDA could me-
diate a similar inhibition, we investigated the effect of 1 M
DDA on the position of the steady-state inactivation curves
of the four types of calcium channels with 20 mM barium as
the external charge carrier. As evident from Fig. 3, DDA
mediated a 10–15-mV shift in half-inactivation potential for
all of the non-L-type channels tested. Thus, unlike farnesol,
inactivated channel block by DDA is not exclusive to N-
type calcium channels. These observations might indicate
that the double bonds and/or the additional methyl side chains
of farnesol (see Fig. 1) could contribute to the N-type channel
selectivity of inactivated channel block. Whereas the shifts in
half-inactivation potential observed with non-L-type channels
do not significantly affect peak current levels at hyperpolarized
holding potentials (i.e., 100 mV, such as in Fig. 2), at a
typical neuronal resting potential (i.e.,70 mV), these shifts in
the midpoint of the steady-state inactivation curve would result
in further depression of peak current amplitude in addition to
that mediated by open and resting channel block. In contrast
with non-L-type channels, application of 1 M DDA did not
significantly affect the position of the steady-state inactivation
curve of 1C, indicating that L-type channels do not undergo
inactivated channel block.
We also tested the effects of 1-dodecanol on the steady-
state inactivation of 1B. As in the case of DDA, a 12 mV
negative shift in half-inactivation potential was observed
(not shown), however, only at 10-fold higher concentrations
(10 M), whereas application of 1 M 1-dodecanol was
ineffective. Together with our previous observation with
FIGURE 3 DDA induces a hyperpolarizing shift in the steady-state inactivation curves of non-L-type channels. Steady-state inactivation curves were
acquired by holding the cells at various conditioning potentials for 5 s prior to stepping to10 mV. 1 MDDA induced a 10 mV to 15 mV hyperpolarizing
shift in inactivation for 1A (control Vh  44.8  0.5 mV, z  3.7; 1 M Vh  57.3  1.3 mV, z  2.5), 1B (control Vh  56.8  0.3 mV, z 
3.56; 1 M Vh  71.2  0.6 mV, z  2.44), and 1E (control Vh  63.6  0.8 mV, z  3.2; 1 M Vh  73.7  0.7 mV, z  2.7). DDA did not
significantly affect the half-inactivation potential of 1C L-type channels (control Vh  19.5  0.4 mV, z  3.7; 1 M Vh  21.4  0.3 mV, z  4.4).
The external barium concentration was 20 mM.
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farnesol, where a shift of similar magnitude was observed at
concentrations as low as 100 nM (Roullet et al., 1999), these
data indicate that the functional group on the dodecyl back-
bone and the actual backbone structure contribute to the
affinity for the inactivated state of N-type channels.
DDA block of L-type and N-type channels differs
in its use-dependence
From the observation that L-type calcium channels predom-
inantly exhibit resting channel block, whereas the non-L-
type isoforms also show substantial inactivated and open
channel block, one might predict a selective use-depen-
dence of DDA action on non-L-type channels. Under con-
trol conditions with 1B or 1C (open symbols, Fig. 4, C and
D), increasing the pulse frequency mediated only a small
(5%) degree of current inhibition, indicating that little
inactivation accumulates in the absence of DDA even at the
highest pulse frequency (2 Hz) used. Fig. 4, A and B depict
the effect of a 2 Hz stimulation on current levels before (left
traces) and after complete (2 min) equilibration (right
traces) with DDA. Under those conditions, the first test
FIGURE 4 Frequency-dependence of DDA block. Frequency protocols consisted of 20 test pulses from 100 mV to various potentials at 0.3, 0.6, 1.0,
or 2.0 Hz. Protocols were administered in random order and followed by 60-s recovery periods. One M DDA was applied 30 s after the last frequency
protocol in control conditions and allowed to equilibrate for 2 min prior to resumption of the pulse protocol. (A and B) Representative current traces of the 1st,
10th, and 20th steps of a 2 Hz protocol for N-type (1B, 2-, 1b) and L-type (1C, 2-, 1b) calcium channels, respectively. Left traces show control currents
and right traces were recorded in the presence of 1 M DDA. Scale bars apply to both left and right traces, all experiments were performed in 20 mM external
barium. Note that additional block of N-type channels developed during the train, whereas L-type channels did not undergo further inhibition after the first pulse.
(C andD) Frequency-dependence plots in control (open symbols) and 1 MDDA (filled symbols) conditions for 1B and 1C. Data are plotted as the ratio between
the current amplitudes obtained at the 20th and the 1st pulse for each frequency train, under both control and DDA conditions. Data were tested for significant
differences between control and DDA data via paired t-tests (*p  0.05). DDA induced significant frequency-dependence at both 1 (p  0.03) and 2 Hz (p 
0.02) frequencies. (E and F) Comparison of total block by 1 M DDA as measured by the original step protocol at 0.066 Hz (see Fig. 2) and the
frequency-dependence protocol at 2 Hz. Data are plotted as the ratio of the peak current amplitudes obtained at the 20th step in the absence and the presence of
DDA. Block by DDA as measured by the 2 Hz protocol was significantly different from block at 0.066 Hz of 1B (t-test, p  0.03) but not 1C currents (1B:
0.066 Hz Ipeak  25.6  4.3%, 2 Hz Ipeak  45.0  7.3%; 1C: 0.066 Hz Ipeak  62.8  5.6%, 2 Hz Ipeak  64.4  8.5%).
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pulse in the train after drug equilibration reveals tonic peak
current block of, respectively, 20  5% and 48  6% for
1B and 1C. As the train continues, significant use-depen-
dent block develops for 1B, but not for 1C. This can be
seen upon comparison of the current levels obtained during
the 1st, 10th, and 20th pulses in the train and is further
illustrated in Fig. 4, C and D for a series of different pulse
train frequencies. As evident from the figure, 1B, but not
1C, channels accumulated a significant additional block at
1 and 2 Hz stimulus rates compared with slower rates of
stimulation. Fig. 4, E and F compare total peak current
amplitude inhibition by DDA in the 2 Hz pulse protocol and
the original (0.066 Hz) step protocol used in Fig. 2 B.
Besides the open channel and tonic blocking components
described earlier, higher frequency stimulation produced an
additional 20% block of 1B channels, whereas 1C chan-
nels were not significantly affected. The lack of use-depen-
dence observed with 1C is consistent with the idea that
these channels undergo predominantly resting channel
block. Overall, our data further support the notion that
L-type channel block by DDA differs from that of non-L-
type channels in its state-dependence.
DDA block of L-type and N-type channels differs
in its sensitivity to [Ba]o
We have previously hypothesized that open channel block
by farnesol might occur via physical occlusion of the pore
(Roullet et al., 1999). One feature frequently associated with
pore block is a dependence of blocking affinity on the
concentration of external carrier ion. To test whether such a
characteristic could be observed with DDA, we reduced the
concentration of external permeant ion from 20 mM to 2
mM and assessed the change in blocking affinity for N-type
and L-type channels. Fig. 5, A and B depict the effects of
DDA in the form of representative current traces obtained in
20 mM (from Fig. 2 A) and 2 mM external barium solutions.
For 1B, the degree of peak current inhibition by DDA was
dramatically enhanced in 2 mM barium. Furthermore, in
lower external saline, the speeding of the time course of
current decay was observed at lower DDA concentrations,
consistent with our interpretation that the enhanced decay
rate in the presence of DDA reflected open channel block.
Analysis of the rate of current decay in 2 mM barium
solution revealed a 52% increase in the association rate
FIGURE 5 Selective dependence of N-type channel block by DDA on the concentration of external barium ions. DDA block of 1B and 1C was assessed
in either 2 mM or 20 mM external barium solution using a step protocol from 100 mV to10 mV. (A and B) Representative current traces of DDA block
in 20 mM (filled symbols) and 2 mM (open symbols) external barium solution for 1B and 1C, respectively. The magnitude of the vertical scale bar is
indicated for each trace; all horizontal scale bars reflect 20 ms. Note that N-type channels become more sensitive to DDA in lower external saline. (C and
D) Dose-response curves for DDA block under both external barium concentrations were fit with the Hill equation. Individual data points are means from
4 to 10 determinations. The data obtained in 20 mM barium are the same as those shown in Fig. 2 B. 1B currents were blocked with IC50 values of 1.8 
0.2 M for 20 mM barium (nh  1.7) and 0.4  0.1 M for 2 mM barium solution (nh  1.2). Alternately, 1C currents showed IC50 values of 0.8 
0.1 M (nh  2.4) and 1.1  0.1 M (nh  1.6) in 20 mM and 2 mM external barium, respectively.
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constant (kon) and a 12% decrease in the dissociation rate
constant (koff) compared to 20 mM barium, indicating a
slightly less than twofold increase in blocking affinity in
lower external barium solution. In contrast, 1C currents
actually underwent, if anything, a slight decrease in block-
ing affinity when external barium was reduced to 2 mM.
This is further illustrated in form of dose-response curves
(Fig. 5, C and D) for peak current inhibition. Whereas
reduction of external charge carrier concentration had little
effect on 1C channels, the IC50 for DDA block of 1B was
decreased approximately fivefold. In view of the relatively
moderate effects of charge carrier concentration on the open
channel blocking affinity, the larger effect observed with the
dose-dependence of peak current inhibition of 1B channels
may suggest that both open and resting channel block were
affected, which cannot easily be explained by a simple
competition between barium ions and DDA within the per-
meation pathway. Thus, there appears to be a fundamental
difference in the detailed mechanism by which DDA me-
diates peak current block of N-type and L-type channels.
Finally, of particular note, with an IC50 of 400 nM in 2
mM Ba2, DDA is among the most potent small organic
inhibitors of N-type channel activity described to date,
which is remarkable in view of the structural simplicity of
the compound.
Blocking affinity for N-type channels depends on
hydrocarbon chain length
To examine whether block of N-type calcium channels by
aliphatic monoamines might be dependent on the length of
the hydrocarbon backbone, we systematically varied the
backbone chain length while keeping the functional amine
headgroup constant. Eight additional commercially avail-
able aliphatic monoamines ranging in chain length from 9 to
18 carbons were tested on N-type calcium channels bathed
in 20 mM barium saline at a holding potential of 100 mV.
Fig. 6 illustrates peak current block by each of these com-
pounds at a concentration of 10 M. A pattern of chain
length-dependence is readily observable. C12 (DDA) and
C13 (tridecylamine) abolished virtually all of the current.
With decreasing hydrocarbon chain length, blocking affin-
ity became progressively reduced from 73  7% block
(C11) to 21 3% block (C9). Likewise, as chain length was
increased, the degree of N-type channel block decreased
monotonically to 7  3% for C18. Overall, it appears as if
a chain length of 12 or 13 carbons yields optimum condi-
tions for N-type channel block. Thus, the three-dimensional
makeup of the drug binding site on the N-type calcium
channel molecule appears to place strict physical constraints
on the size of drug molecule it can accommodate, which in
turn may provide insights into the pore structure.
DISCUSSION
Comparison with farnesol block
In our previous study on farnesol, we demonstrated that
farnesol caused two types of inhibition of voltage-depen-
dent calcium channels: a low affinity inhibition that showed
a slight preference for L-type channels, but was nonetheless
relatively nonselective for different types of HVA channels,
and a higher affinity inactivated channel block that was
selective for N-type channels (Roullet et al., 1999). There
are three major structural differences between DDA and
farnesol (see Fig. 1), as DDA lacks the three double bonds
and methyl groups in the backbone, and the terminal -OH
group of farnesol is replaced by an amine. It is perhaps not
surprising to note that DDA action differed from that of
farnesol in several ways. First, DDA block (at a holding
potentials of 100 mV) occurred with 10-fold higher affin-
ity. Second, while this type of inhibition retained a slight
preference for L-type channels, the contribution of resting
channel block to the overall peak current block seen with
non-L-type channels was much greater than that observed
with farnesol. Third, whereas the ability to block inactivated
N-type channels was retained in DDA, its selectivity for
N-type channels was lost.
Despite these differences, several qualitative features of
farnesol block were also seen with DDA. For example,
DDA block of L-type and non-L-type channels differed in
its state-dependence. Like farnesol, DDA has the general
ability to interact with multiple kinetic states of the channel.
Finally, both farnesol and DDA accelerated the rate of
FIGURE 6 Block of transiently expressed (1B  2-  1b) N-type
calcium channels by aliphatic monoamines is dependent on hydrocarbon
chain length. All compounds were applied at a concentration of 10 M in
20 mM external barium solution using a standard step protocol (holding
potential 100 mV, test potential 10 mV). Cn indicates the length of the
hydrocarbon backbone for each of the amines. The data are plotted as the
percentage of current remaining after drug application. Blocking affinity
was greatest for DDA (C12; current remaining 2.7  1.3%) and tride-
cylamine (C13, current remaining 1.0  1.0%) with decreasing effect as
hydrocarbon chain length was either increased or decreased.
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current decay and showed an increase in blocking affinity in
lower concentrations of external barium in a manner con-
sistent with an open channel blocking mechanism (Roullet
et al., 1999). Nonetheless, whereas the general blocking
mechanisms of farnesol are retained in the structurally much
more rudimentary DDA molecule, many of the detailed
aspects of calcium channel block by these two molecules
appear quite distinct.
Effect of DDA on other membrane proteins
A wide diversity of biological actions of DDA have been
reported in the literature, ranging from enhancement of skin
permeation for drug delivery (Aungst et al., 1990) to inhi-
bition of osmotic-sensitive calcium influx in bacteria
(Beeler et al., 1997). However, DDA is perhaps best known
as an inhibitor of the cardiac sodium/calcium exchanger.
Philipson (1984) demonstrated 60% inhibition of Na-
dependent Ca2 uptake by the canine cardiac Na/Ca2
exchanger with 20 M DDA, while a Ki of 3 M has been
reported for DDA inhibition of frog atrial “creep” currents,
the electrogenic current generated by Na/Ca2 exchange
(Bielefeld et al., 1986). Consistent with our data on L-type
channels (IC50  0.8 M), Bielefeld reported that blocking
affinity for myocardial L-type calcium and potassium cur-
rents occurred within the same range as block of exchange
activity. In contrast, Terrar and White (1989) argued that
DDA effects on cardiac calcium channels were only mini-
mal compared to inhibition of Na/Ca2 exchange. Our
results obtained with N-type channels in 2 mM external
barium (IC50 of 400 nM), together with the added inacti-
vated channel block that would be present at a typical
neuronal resting membrane potential, suggest that calcium
channels may be much more sensitive to DDA than other
ion transport molecules. Nonetheless, the observation that
DDA is capable of inhibiting multiple types of cation trans-
port proteins might reflect a common blocking mechanism.
Based on the dependence of blocking affinity on external
carrier ion concentration, one likely site of action of DDA is
in the channel pore. Many types of cation channels share a
similar P-loop motif, thus providing ample opportunity for
conserved structures that may form the receptor site for
DDA and related compounds. Consistent with such a mech-
anism, a number of monoamines have been shown to block
inward rectifier potassium channels (Pearson and Nichols,
1998), and several of the structurally related quaternary
ammonium compounds are potent pore blockers of voltage-
dependent sodium channels (Wang et al., 1991).
Drug-structural requirements for N-type
channel block
Several hydrocarbon molecules with different functional
headgroups have been shown to block calcium channels.
For example, acidic omega-3 fatty acids (Leaf, 1995) have
been reported to potently inhibit L-type calcium channels.
In addition, compounds such as farnesol (Roullet et al.,
1999) and aliphatic alcohols (Hawthorn et al., 1992) block
calcium channels at micromolar concentrations. Therefore,
one might expect the functional group to be relatively
unimportant. Our finding that 1-dodecanol, n-dodecane,
4-dodecylphenol, and dodecylacetate show 15% block at
10 Mwould have been consistent with this idea. However,
addition of a terminal amine (as in DDA) resulted in an
almost 30-fold increase in blocking affinity compared with
these other compounds. Thus, the functional group can be a
major determinant of blocking efficacy of aliphatic mono-
amines. Additional structural derivatives will ultimately
need to be examined to assess whether the addition of an
amine group can generally enhance the blocking affinity of
carbon chain molecules for calcium channels.
When comparing the effects of 1-dodecanol, DDA, and
farnesol on steady-state inactivation of N-type channels, we
can draw two conclusions. Compared with DDA, 1-dode-
canol required 10-fold higher concentrations to mediate the
same shift in half-inactivation potential, suggesting that the
functional group contributes to the affinity for inactivated
channels. Furthermore, farnesol, which carries the same
functional group as 1-dodecanol, was 100-fold more effec-
tive in shifting the half-inactivation potential, strongly sug-
gesting that the nature of the backbone structure is also
critical for inactivated channel block.
We also observed a very sharp dependence of blocking
affinity on hydrocarbon chain length for a series of aliphatic
monoamines, with C12 and C13 compounds being most
effective. While we cannot completely rule out the possi-
bility that the longer molecules show a reduced degree of
solubility, the reduced affinity seen with the longer com-
pounds could also indicate that the blockers become too
large to be properly accommodated by the binding site.
Conversely, the lower blocking affinity observed with the
shorter compounds could reflect an inability of these com-
pounds to fully interact with all of the “microsites” con-
tained within the overall drug-binding pocket on the chan-
nel. The dependence of blocking affinity on hydrocarbon
chain length is not unique to voltage-dependent calcium
channels. Experiments on inward rectifier K channels re-
vealed voltage-dependent block by monoamines that
showed increasing potency and slower unblocking rates as
the chain length was progressively increased from C5 to
C12 (Pearson and Nichols, 1998). For open channel block
of batrachotoxin-activated sodium channels by quaternary
amines, increasing the side chain length from 12 to 18
carbons mediated an increase in mean blocked time (Wang
et al., 1991). Furthermore, the authors identified a bell-
shaped relation between blocking kinetics and carbon chain
length. Philipson (1984) tested several aliphatic amines
ranging from C8 to C16 (including DDA) and showed a
progressively increasing potency for Na/Ca2 exchange
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inhibition. These data contrast with our finding that block-
ing affinity decreases as alkylamine chain length is in-
creased past C13 and further differentiates the effects of
alkylamines on Na/Ca2 exchangers and Ca2 channels.
This may argue against the possibility that our observations
with longer chain compounds are due to a simple solubility
effect.
Mechanism of DDA block
Based on the observation that open channel block by far-
nesol seemed to require diffusion of the compound into the
membrane phase, we had suggested that farnesol might
perhaps act as a pore blocker from the cytoplasmic side of
the channel (Roullet et al., 1999). Unlike farnesol, dode-
cylamine contains a tertiary amine with a pKa of 10.6, and
thus DDA is essentially permanently charged at physiolog-
ical pH and unavailable for crossing the plasma membrane.
In several experiments, we added 10 M DDA to the
internal recording solution, and after 10 min of dialysis, we
did not detect any significant block of N-type channels
(Beedle and Zamponi, unpublished observations). Con-
versely, the rate constants for open channel block are three
orders of magnitude faster than that required for equilibra-
tion of the drug, consistent with at least partial entry into the
membrane phase rather than a simple pore occlusion mech-
anism from the external side of the channel. It is possible
that the blocking site could be accessible via a membrane-
delimited pathway similar to what has been proposed for
lidocaine block of batrachotoxin-activated sodium channels
(Zamponi et al., 1993a, b). If so, the terminal nitrogen
moiety would remain confined to the extracellular side,
whereas the hydrophobic tail end might access the actual
blocking site. Such a mechanism could account for the
observation that blocking affinity becomes reduced with
decreasing carbon chain length and would space the drug
binding site 10–15 Å into the lipid bilayer from the
external side. However, how can such a model account for
the observation that 1-dodecanol was only poorly effective
in blocking N-type channel activity, despite sharing an
identical backbone with DDA and being able to freely
partition into the membrane phase? Clearly, the simple
presence of the charged amino group dramatically enhances
blocking affinity, but does not appear to be required for
block (note that all of the compounds displayed in Fig. 1
show qualitatively similar block). It is conceivable that
negative surface charges on the extracellular face of the
membrane and/or the channel may serve to increase the
local concentration of protonated DDA, thus resulting in an
apparent increase in blocking affinity. The less effective
surface charge screening associated with a reduction of the
external divalent ion concentration would result in addi-
tional DDA accumulation near the membrane, thus provid-
ing a possible explanation for the higher DDA affinity for
1B channels in lower ionic strength saline. However, the
notion that this did not occur with L-type channels would
argue against a diffuse membrane surface charge effect.
Alternatively, the amino group of DDA could bind to one or
more specific residues on the extracellular face of the chan-
nel protein, thereby facilitating the interaction between the
hydrophobic tail and the functional blocking site on the
channel. Ultimately, however, additional analogs such as
quaternary derivatives will need to be examined to further
substantiate our current hypothesis.
In summary, DDA is a remarkably simple compound
capable of producing calcium channel block with submicro-
molar affinity. The observation that subtype specificity and
blocking affinity of these carbon chain molecules can be
dramatically altered with relatively small structural changes
suggests that structural derivatives of this class of molecules
may perhaps yield novel, high affinity blockers selective for
certain types of voltage-dependent calcium channels.
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